NYSE$UNH

UnitedHealth · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

UnitedHealth Group's first quarter performance was reported, showing revenue growth and strong earnings from operations.

UnitedHealth Group reported a strong first quarter with revenues of $70.2 billion, a 9% increase year-over-year, and earnings from operations growing by 35% to $6.7 billion. The company's performance was driven by balanced growth at both Optum and UnitedHealthcare. They also increased their full year net earnings outlook to $17.15 to $17.65 per share and adjusted earnings to $18.10 to $18.60 per share.

  • Revenues grew by 9% to $70.2 billion, driven by balanced growth in Optum and UnitedHealthcare.
  • Earnings from operations increased by 35% to $6.7 billion.
  • Cash flows from operations were $6.0 billion, representing 1.2 times net income.
  • Net earnings per share were $5.08, and adjusted earnings per share were $5.31.

Headline financials

Total Revenue

$70.2B

Previous: $64.4B+9.0%
EPS (adj)

$5.31

Previous: $3.72+42.7%
Optum Health Consumers

99.0M

No prior period
Capital Expenditures

-$568M

Previous: -$469M-21.1%
Free Cash Flow

$4.29B

Previous: $2.91B+47.4%
Net Income

$4.86B

Previous: $3.38B+43.8%
Operating Income

$6.74B

Previous: $5B+34.9%
Gross Profit

$62.6B

Previous: $56.7B+10.4%
Cash & Equivalents

$20B

Previous: $21.6B-7.5%
Total Assets

$205B

Previous: $189B+8.5%
Stock-Based Comp

$256M

Previous: $231M+10.8%

Revenue & EPS history

UnitedHealth · Revenue · Quarterly

$70.2B

Q1 2021+9%vs Q1 2020
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

UnitedHealth · $70.2B total across 4 segments · Q1 2021

  • Premiums
    $55.5B+9.6%
  • Products
    $8.34B-1.1%
  • Services
    $5.92B+18.7%
  • Investment & Other
    $452M+23.8%

Forward guidance

The Company increased its full year net earnings outlook to $17.15 to $17.65 per share and adjusted earnings to $18.10 to $18.60 per share. This outlook continues to include approximately $1.80 per share in potential net unfavorable impact to accommodate continuing COVID-19 effects, such as: testing and treatment costs; the residual impact of people having deferred care in 2020; and unemployment and other economy-driven factors.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.9%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+2.6%

Avg return

30 days after

63%

46 / 73 earnings

Positive

+11.2%

Q2 2024

Best reaction

-22.4%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+9.7%+18.1%
Q4 2025-11.2%-18.4%-18.5%
Q3 2025+0.1%-6.7%-9.9%
Q2 2025+0.6%+21.2%+38.2%
Q1 2025-22.4%-27.0%-50.1%
Q4 2024-6.2%-3.4%-3.7%
Q3 2024-5.6%-5.9%-2.0%
Q2 2024+11.2%+9.7%+12.5%
Q1 2024+7.5%+12.5%+17.0%
Q4 2023-3.8%-2.7%-4.0%
Q3 2023+2.4%+2.0%+3.0%
Q2 2023+8.1%+12.5%+13.5%
Q1 2023-4.0%-7.6%-6.7%
Q4 2022-2.1%-3.9%-0.3%
Q3 2022+2.3%+2.0%+2.4%
Q2 2022+3.4%+3.4%+8.2%
Q1 2022-0.5%+0.1%-9.6%
Q4 2021+0.4%+0.3%+1.5%
Q3 2021+6.1%+5.2%+13.7%
Q2 2021+1.2%-0.4%-1.2%
Q1 2021+4.1%+5.6%+9.1%
Q4 2020+0.8%-1.2%-7.8%
Q3 2020-2.1%-2.2%+7.3%
Q2 2020-0.4%-1.6%+4.9%
Q1 2020+10.3%+4.3%+7.6%
Q4 2019+4.3%+3.5%+3.7%
Q3 2019+7.4%+11.2%+16.0%
Q2 2019-3.8%-4.4%-7.9%
Q1 2019-5.8%-3.7%+2.9%
Q4 2018+5.4%+7.0%+7.0%
Q3 2018+2.7%+1.9%+1.8%
Q2 2018-0.6%-1.7%+2.4%
Q1 2018+2.6%+2.1%+5.5%
Q4 2017+4.3%+6.4%-1.1%
Q3 2017+6.2%+7.4%+9.3%
Q2 2017+1.5%+2.9%+3.4%
Q1 2017+1.2%+2.4%+2.6%
Q4 2016-2.5%-1.9%+1.1%
Q3 2016+7.6%+8.4%+12.4%
Q2 2016+1.6%+2.1%+1.0%
Q1 2016+4.8%
Q4 2015+5.1%
Q3 2015-1.7%
Q2 2015-1.6%
Q1 2015+1.2%
Q4 2014+7.8%
Q3 2014+7.3%
Q2 2014+2.1%
Q1 2014-4.1%
Q4 2013-3.1%
Q3 2013-8.6%
Q2 2013+7.9%
Q1 2013-3.2%
Q4 2012+1.7%
Q3 2012-2.6%
Q2 2012-1.7%
Q1 2012+3.8%
Q4 2011+2.3%
Q3 2011-2.2%
Q2 2011-1.7%
Q1 2011+0.5%
Q4 2010+0.7%
Q3 2010-0.5%
Q2 2010+1.6%
Q1 2009-0.8%
Q1 2010-0.2%
Q4 2009+0.4%
Q4 2007+0.4%
Q3 2008+5.5%
Q3 2009+5.5%
Q4 2008+1.3%
Q2 2008+1.3%
Q2 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro